id
name
related bits
0
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-10-08 03:17:15
expired found date
-
created at
2024-06-30 13:01:00
updated at
2026-02-26 12:09:52
length
9
crc
51848
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
408447
mp size raw text
2594
mp inner links count
7
mp inner links status
20 (imported)
title
Takeda Pharmaceuticals: Global Homepage
description
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
site name
author
updated
2026-02-22 01:17:50
raw text
Takeda Pharmaceuticals: Global Homepage Search... GLOBAL | Takeda Pharmaceuticals: Global Homepage Hear from our new Global CSR partners Learn More We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives. Recent News Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years October 3, 2023 Takeda Provides Update on EXKIVITY® (mobocertinib) October 2, 2023 Takeda Announces Amendment of Compensation Recoupment Policy October 2, 2023 U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis September 27, 2023 View All Better Health, Brighter Future Join Us Work with gl...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
1
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
2096
text words
345
text unique words
211
text lines
52
text sentences
12
text paragraphs
4
text words per sentence
28
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
links other domains
5 - takeda.com, takeda.info
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
2 - linkedin.com, youtube.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2026-02-22 01:17:50
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
1 (priority 1 already searched, no matches found)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-